21-23 October 2020
In April 2013, the FDA released the Guidance for Industry "Safety Considerations for Container Labels and Carton Labelling Design to Minimize Medication Errors" as a draft.
The purpose of this document is to provide a range of principles and recommendations for ensuring the correct and safe use of a pharmaceutical product.
Medication errors are a major public health concern which are estimated to cause about 7,000 deaths each year in the USA. Labelling and/ or packaging issues are responsible for around 30% of these incidents.
The Guideline addresses the following topics:
According to further recommendations, differentiation in the product name and strengths should be emphasized.
More detailed information can be found in the FDA document entitled "Safety Considerations for Container Labels and Carton Labeling Design to Minimize Medication Errors".